Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow, Luke A Probst, Christopher D Miller, et al.
Journal of Pharmacy Practice
|
January 24, 2017
Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy
Cory M Hale, Jeffrey M Steele, Robert W Seabury, et al.
Hospital Pharmacy
|
March 28, 2018
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Anne Krasniak, William Darko, Christopher D Miller, et al.
Current Surgery
|
August 30, 2005
Daily evaluation of macroaspiration in the critically ill post-trauma patient
Christopher D Miller, Jill A Rebuck, John W Ahern, et al.
Pharmacotherapy
|
September 20, 2016
Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis
Wesley D Kufel, Adam S Zayac, David F Lehmann, et al.
Hospital Pharmacy
|
June 9, 2020
Publications for Pharmacy Residents Are Challenging but Not "Nearly Unattainable"
Robert Seabury, William Darko, Christopher D Miller, et al.
International Journal of STD & AIDS
|
April 1, 2015
Preemptive antiretroviral therapy modifications for the management of potential clinically significant drug interactions with direct acting hepatitis C therapies
Megan Stambough, Martha Roman, Donald C Blair, et al.
Clinical Therapeutics
|
February 16, 2022
Pharmacists Act on Care Transitions in Stroke (PACT-Stroke): A Systems Approach
Jenna L Harris, Danielle DelVecchio, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 5, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow, Luke A Probst, Christopher D Miller, et al.
Journal of Pharmacy Practice
|
January 24, 2017
Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy
Cory M Hale, Jeffrey M Steele, Robert W Seabury, et al.
Hospital Pharmacy
|
March 28, 2018
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Anne Krasniak, William Darko, Christopher D Miller, et al.
Current Surgery
|
August 30, 2005
Daily evaluation of macroaspiration in the critically ill post-trauma patient
Christopher D Miller, Jill A Rebuck, John W Ahern, et al.
Pharmacotherapy
|
September 20, 2016
Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis
Wesley D Kufel, Adam S Zayac, David F Lehmann, et al.
Hospital Pharmacy
|
June 9, 2020
Publications for Pharmacy Residents Are Challenging but Not "Nearly Unattainable"
Robert Seabury, William Darko, Christopher D Miller, et al.
International Journal of STD & AIDS
|
April 1, 2015
Preemptive antiretroviral therapy modifications for the management of potential clinically significant drug interactions with direct acting hepatitis C therapies
Megan Stambough, Martha Roman, Donald C Blair, et al.
Clinical Therapeutics
|
February 16, 2022
Pharmacists Act on Care Transitions in Stroke (PACT-Stroke): A Systems Approach
Jenna L Harris, Danielle DelVecchio, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 5, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
Page
of 7